Researchers Awarded Prize for the Development of Vital Treatment for Spinal Muscular Atrophy
AxxLC / Pixabay

Researchers Awarded Prize for the Development of Vital Treatment for Spinal Muscular Atrophy

According to a story from the Farmington Daily Times, Dr. C. Frank Bennett, who grew up in Aztec, NM, and his collaborator Dr. Adrian Krainer, were both jointly awarded the…

Continue Reading Researchers Awarded Prize for the Development of Vital Treatment for Spinal Muscular Atrophy
First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA
frolicsomepl / Pixabay

First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA

According to a story from BioSpace, the biopharmaceutical company Sobi and the biotechnology company NovImmune SA have recently announced that the US Food and Drug Administration (FDA) has approved Gamifant,…

Continue Reading First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA
Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease
Source: Pixabay.com

Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease

According to a story from the biotechnology company Amgen, a review from the European Medicines Agency (EMA) has recommended that the indication for blinatumomab, marketed as BLINCYTO®, be expanded. The…

Continue Reading Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease
Potential Treatment for Niemann-Pick Disease is Granted Orphan Drug Designation in the EU
Etereuti / Pixabay

Potential Treatment for Niemann-Pick Disease is Granted Orphan Drug Designation in the EU

According to a story from rdmag.com, the biopharmaceutical company IntraBio Inc., recently announced that its IB1000 series of investigational therapeutic compounds have been granted Orphan Medicinal Drug Designation as a…

Continue Reading Potential Treatment for Niemann-Pick Disease is Granted Orphan Drug Designation in the EU
A Woman With Spinal Muscular Atrophy is Fighting for Access to the Therapy That Could Save Her
source: pixabay.com

A Woman With Spinal Muscular Atrophy is Fighting for Access to the Therapy That Could Save Her

According to a story from MarketWatch, Annie Wilson was diagnosed with spinal muscular atrophy when she was only six months old. With no real treatment options available, doctors told her…

Continue Reading A Woman With Spinal Muscular Atrophy is Fighting for Access to the Therapy That Could Save Her
New Development Deal Struck for Experimental Alagille Syndrome Treatment
rawpixel / Pixabay

New Development Deal Struck for Experimental Alagille Syndrome Treatment

According to a story from prnewswire.com, the drug developer Mirum Pharmaceuticals recently announced that is has entered an agreement with Shire which grants exclusive rights for marketing and development of…

Continue Reading New Development Deal Struck for Experimental Alagille Syndrome Treatment
Ready to Donate to a Rare Patient on GoFundMe? Make Sure you are Paying for Something That Works
source: pixabay.com

Ready to Donate to a Rare Patient on GoFundMe? Make Sure you are Paying for Something That Works

According to a story from ncbnewyork.com, a recent study found that $7 million on donations on crowdfunding sites for medical patients have gone towards treatments that are medically unsound and…

Continue Reading Ready to Donate to a Rare Patient on GoFundMe? Make Sure you are Paying for Something That Works
Is Phage Therapy the Best Hope for Cystic Fibrosis Patients That Can’t be Treated With Antibiotics?
source: pixabay.com

Is Phage Therapy the Best Hope for Cystic Fibrosis Patients That Can’t be Treated With Antibiotics?

According to a story from Buzzfeed News, Paige Rogers was 21 years old when she was admitted to the hospital. She was having trouble breathing because of cystic fibrosis. Over…

Continue Reading Is Phage Therapy the Best Hope for Cystic Fibrosis Patients That Can’t be Treated With Antibiotics?
Proof of Concept Data Highlights Viability of Gene Therapy for Metachromatic Leukodystrophy
source: pixabay.com

Proof of Concept Data Highlights Viability of Gene Therapy for Metachromatic Leukodystrophy

According to a story from Market Screener, the genetic medicines company Homology Medicines, Inc., recently announced the presentation of data which revealed that the company's proprietary virus vectors, which are…

Continue Reading Proof of Concept Data Highlights Viability of Gene Therapy for Metachromatic Leukodystrophy
This Drug Just Earned Orphan Drug Designation for Pulmonary Alveolar Proteinosis
felixioncool / Pixabay

This Drug Just Earned Orphan Drug Designation for Pulmonary Alveolar Proteinosis

According to a story from BioSpace, the biotechnology company Partner Therapeutics, Inc., recently announced that the US Food and Drug Administration (FDA) has granted Orphan Drug designation to the company's…

Continue Reading This Drug Just Earned Orphan Drug Designation for Pulmonary Alveolar Proteinosis
CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma
source: pixabay.com

CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma

According to a story from Hematology Times, an experimental CAR-T cell therapy called P-BCMA-101 was recently granted regenerative medicine advanced therapy (RMAT) designation from the US Food and Drug Administration.…

Continue Reading CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma
A Real-Life Dallas Buyers Club? Cutting Long Lines and Buying Prescription Drugs Online
source: pixabay.com

A Real-Life Dallas Buyers Club? Cutting Long Lines and Buying Prescription Drugs Online

In the movie "Dallas Buyers Club" the main character, Ron Woodroof, contracts HIV/AIDs and starts getting drugs from an organization that imports medicine from Mexico. Similarly, many London patients are…

Continue Reading A Real-Life Dallas Buyers Club? Cutting Long Lines and Buying Prescription Drugs Online

ICYMI: Potential Treatment in the Works for Familial Amyotrophic Lateral Sclerosis

According to a story from telegram.com, a group of researchers from the University of Massachusetts medical school recently announced that they may have reached a major treatment breakthrough for genetically…

Continue Reading ICYMI: Potential Treatment in the Works for Familial Amyotrophic Lateral Sclerosis